Risk of Venous Thromboembolism with Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-enriched Rheumatoid Arthritis Patients

By sjmartinez • March 14, 2024

Charles-Schoeman C, Fleischmann R, Mysler E, Greenwald M, Ytterberg SR, Koch GG, Bhatt DL, Wang C, Mikuls TR, Chen AS, Connell CA, Woolcott JC, Menon S, Chen Y, Lee K, Szekanecz Z. Risk of Venous Thromboembolism with Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-enriched Rheumatoid Arthritis Patients. Arthritis Rheumatol. 2024 Mar 13. doi: 10.1002/art.42846. Epub ahead of print. PMID: 38481002.

Tags: Publications, Rheumatology

Targeting triple-negative breast cancer using cord-blood CD34⁺ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activity

Li YR, Shen X, Zhu Y, Li Z, Hon R, Tian Y, Huang J, Zhao AS, Ma NY, Zhang C, Lin D, Sargsyan K, Yuan[...]

Pulmonary Rehabilitation Referral Practice Patterns Across Lung Transplantation Centers in the United States: A Multicenter Survey-Based Study

Deleija JD, Shah SZ, Felzer J, Tan X, Garvey C, DeCato TW, Pennington K, Sehgal S, Kennedy C, Kumar A. Pulmonary Rehabilitation Referral Practice Patterns[...]

Cardiovascular Outcomes in Patients With Cancer Undergoing Cardiac Implantable Electronic Device Implantation

Krishan S, Agarwal S, Munir MB, Ajijola O, Yang EH, Deswal A, Torbey E, Cheng R, Asad ZUA. Cardiovascular Outcomes in Patients With Cancer Undergoing[...]